Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery

被引:33
|
作者
Al Harakeh, Ayman B. [3 ]
Burkhamer, Kyle J. [2 ]
Kallies, Kara J. [2 ]
Mathiason, Michelle A. [2 ]
Kothari, Shanu N. [1 ]
机构
[1] Gundersen Lutheran Hlth Syst, Dept Gen Surg, La Crosse, WI 54601 USA
[2] Gundersen Lutheran Med Fdn, Dept Surg Res, La Crosse, WI USA
[3] Gundersen Lutheran Med Fdn, Dept Med Educ, La Crosse, WI USA
关键词
Laparoscopic gastric bypass; Insurance; Denial; Co-morbidities; Morbid obesity; GASTROESOPHAGEAL-REFLUX DISEASE; Y GASTRIC BYPASS; WEIGHT-LOSS; SURVIVAL; DENIALS; IMPACT;
D O I
10.1016/j.soard.2010.08.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients satisfying the National Institutes of Health criteria and deemed appropriate candidates often do not undergo bariatric surgery for insurance-related reasons. Our objective was to explore the natural history of these patients compared with that of those who underwent laparoscopic Roux-en-Y gastric bypass (LRYGB). Methods: The medical records of the patients evaluated for LRYGB from 2001 to 2007 were retrospectively reviewed. The presence of co-morbidities was assessed at the initial evaluation and within a 3-year follow-up period for patients who had undergone LRYGB and those denied surgery. The statistical analysis included chi-square tests. Results: A total of 189 patients were in the denied cohort and 587 in the LRYGB cohort. The age, gender, and body mass index were similar between the 2 cohorts at the initial evaluation. The percentage of patients with a diagnosis of a co-morbidity in the denied and LRYGB cohorts at the initial evaluation was 20% and 25% with diabetes mellitus, 51% and 43% with hypertension, 20% and 22% with obstructive sleep apnea, 34% and 24% with lipid disorders, and 62% and 49% with gastroesophageal reflux disease, respectively. The body mass index at the initial evaluation and during follow-up was 47.3 and 46.8 kg/m(2) in the denied cohort (n = 165, P = .236) and 48.5 and 30.5 kg/m(2) in the LRYGB cohort (n = 544, P < .001), respectively. During the follow-up period, a greater incidence of new-onset diabetes (P < .001), hypertension (P < .001), obstructive sleep apnea (P < .001), gastroesophageal reflux disease (P < .001), and lipid disorders (P < .001) was observed in the denied cohort. Conclusion: Patients denied LRYGB had a greater incidence of new co-morbidities diagnosed within a short follow-up period, without a significant change in their body mass index. (Surg Obes Relat Dis 2010;6:591-596.) (C) 2010 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 50 条
  • [31] Morbid obesity, nonalcoholic fatty liver disease, metabolic syndrome and bariatric surgery
    Silvestre Teruel, V.
    Ruano Gil, M.
    Garcia Garcia-Lescun, M. C.
    Aguirregoicoa Garcia, E.
    Criado Gomez, L.
    Rodriguez Pinero, A.
    Marco Mur, A. L.
    Garcia-Blanch, G.
    OBESITY SURGERY, 2007, 17 (02) : 283 - 283
  • [32] METABOLIC FEATURES OF CHINESE INDIVIDUALS WITH MORBID OBESITY BEFORE BARIATRIC AND METABOLIC SURGERY Type 2 diabetes and metabolic surgery
    Li, M.
    Liu, Y.
    Zhang, P.
    Zhang, Z.
    OBESITY SURGERY, 2019, 29 : 594 - 594
  • [33] Bariatric and metabolic surgery in patients with morbid obesity and multiple sclerosis-a nationwide, matched cohort study
    Stenberg, Erik
    Forsberg, Lars
    Hedstrom, Anna
    Hillert, Jan
    Naslund, Erik
    SURGERY FOR OBESITY AND RELATED DISEASES, 2021, 17 (06) : 1108 - 1114
  • [34] Bariatric Surgery: Consequences on Functional Capacities in Patients With Obesity
    Reinmann, Aline
    Gafner, Simone Chantal
    Hilfiker, Roger
    Bruyneel, Anne-Violette
    Pataky, Zoltan
    Allet, Lara
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [35] BARIATRIC SURGERY: A WAY TO TREAT MORBID OBESITY
    Monteiro, Andreia
    de Angelis, Isabella
    RBONE-REVISTA BRASILEIRA DE OBESIDADE NUTRICAO E EMAGRECIMENTO, 2007, 1 (03): : 19 - 26
  • [36] Economic considerations for bariatric surgery and morbid obesity
    Frezza, Eldo E.
    Wacthell, Mitchell
    Ewing, Bradley
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2009, 1 : 79 - 83
  • [37] Contribution of Bariatric Surgery to the Comprehension of Morbid Obesity
    Picard Marceau
    Obesity Surgery, 2005, 15 : 3 - 10
  • [38] Bariatric surgery is an effective treatment for morbid obesity
    Schigt, A.
    Gerdes, V. E. A.
    Cense, H. A.
    Berends, F. J.
    van Dielen, F. M. H.
    Janssen, I.
    van der Laar, A.
    van Wagensveld, B. A.
    Romijn, J. A.
    Serlie, M. J.
    NETHERLANDS JOURNAL OF MEDICINE, 2013, 71 (01): : 4 - 9
  • [39] Bariatric surgery for treatment of morbid obesity in adults
    Park, Ki Bum
    Jun, Kyong-Hwa
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2025, 40 (01): : 24 - 39
  • [40] Severe psoriasis, morbid obesity and bariatric surgery
    Perez-Perez, L.
    Allegue, F.
    Caeiro, J. L.
    Zulaica, J. M. Fabeiro A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (07) : e421 - e422